endocrine/exocrine glands
N |
• pancreatic beta cell mass and number of islets per pancreas area
• pancreatic beta cell mass and number of islets per pancreas area following glucagon receptor (Gcgr) antibody administration
|
• 50% reduced hyperplasia following glucagon receptor (Gcgr) antibody administration compared to wild-type
• alpha cell size following glucagon receptor (Gcgr) antibody administration
• alpha cell mass and size
|
growth/size/body
N |
• body, pancreas and liver weights
|
homeostasis/metabolism
N |
• blood glucose level, plasma amino acids, glucagon and insulin levels, oral glucose tolerance and insulin sensitivity, pancreas glucagon and insulin levels
|